scispace - formally typeset
S

Shlomo Almog

Researcher at Sheba Medical Center

Publications -  60
Citations -  7197

Shlomo Almog is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Warfarin & Hyperinsulinemia. The author has an hindex of 28, co-authored 60 publications receiving 6857 citations. Previous affiliations of Shlomo Almog include Tel Aviv University.

Papers
More filters
Journal ArticleDOI

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

TL;DR: It is concluded that insulin resistance and/or hyperinsulinemia are present in the majority of hypertensives, constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.
Journal ArticleDOI

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

TL;DR: The identification in porcine brain of arachidonic acid ethanolamide, the structural elucidation, and the synthesis of two novel fatty acid ethanolamides which bind to the cannabinoid receptor are reported.
Journal ArticleDOI

Interindividual variability in sensitivity to warfarin-Nature or nurture?

TL;DR: Interindividual variability in responses to warfarin is attributed to dietary vitamin K, drug interactions, age, or genetic polymorphism in the cytochrome P450 2C9 enzyme (CYP2C9) linked with impaired metabolism of the potent enantiomere S ‐warfarin.
Journal ArticleDOI

Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy

TL;DR: Thiamine repletion can improve left ventricular function and biochemical evidence of thiamine deficiency in some patients with moderate-to-severe CHF who are receiving longterm furosemide therapy.